Clinical Trials
84 trialsPhase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Fox Chase Cancer Center
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
Xijing Hospital
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution
Northwestern University
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
University of Pittsburgh
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Rhode Island Hospital
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
H. Lee Moffitt Cancer Center and Research Institute
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
Ohio State University Comprehensive Cancer Center
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
H. Lee Moffitt Cancer Center and Research Institute
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Shanghai Juncell Therapeutics
Mel 70
University of Virginia
CITY
Assistance Publique - Hôpitaux de Paris
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
Dana-Farber Cancer Institute
Zr89 + PET Companion Trial
Abramson Cancer Center at Penn Medicine
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
Mayo Clinic
FAST-CR
The University of Hong Kong-Shenzhen Hospital
MELRIV-1
Centre Jean Perrin
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
University of Massachusetts, Worcester
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
University of Southern California
MB-CART20.1 Melanoma
Miltenyi Biomedicine GmbH
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Xijing Hospital
Tilmanocept
University of Lausanne Hospitals
Mel61
University of Virginia
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer
Center for Biomedical Research, Inc.
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)
University of Pennsylvania
MPAK
Columbia University
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Ohio State University Comprehensive Cancer Center
Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Rutgers, The State University of New Jersey
pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma
TuHURA Biosciences, Inc.
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes
Yale University
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
YSCH-01
Shanghai Fengxian District Central Hospital
Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor
University of Missouri-Columbia
Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions
Northwestern University
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma
Yale University
Topical Vitamin C for Treatment of Basal Cell Cancer
Center for Biomedical Research, Inc.
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Northwestern University
NICE
Rhode Island Hospital
Topical Itraconazole in the Treatment of Basal Cell Carcinoma
Johns Hopkins University
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
Tulane University